Elevated soluble urokinase receptors in focal segmental glomerulosclerosis: A role for IL-2?

Kidney International

Volumn 85, Issue 6, 2014, Pages 1469-1470

  Park, Se Jin ^a   Saleem, Moin A ^b   Shin, Jae Il ^c  

^a Ajou University Medical CentSuwon   (South Korea)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 2; METHYLPREDNISOLONE; RNA BINDING PROTEIN; UROKINASE RECEPTOR;

DISEASE ACTIVITY; DOWN REGULATION; DRUG MEGADOSE; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY TRANSPLANTATION; LETTER; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; REMISSION; SEZARY SYNDROME; UPREGULATION; BLOOD; FEMALE; MALE;

FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84901857292     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.90     Document Type: Letter

References (9)

1. Jefferson JA, Shankland SJ. Has the circulating permeability factor in primary FSGS been found? Kidney Int 2013; 84: 235-238.
2. Huang J, Liu G, Zhang YM et al. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis. Kidney Int 2013; 84: 366-372.
3. Jordan SC, Querfeld U, Toyoda M et al. Serum interleukin-2 levels in a patient with focal segmental glomerulosclerosis. Relationship to clinical course and cyclosporin A therapy. Pediatr Nephrol 1990; 4: 166-168.
4. Cather JC, Jackow C, Yegge J et al. Mycosis fungoides with focal segmental glomerular sclerosis and nephrotic syndrome. J Am Acad Dermatol 1998; 38: 301-305.
5. Hassel JC, Meier R, Joller-Jemelka H et al. Serological immunomarkers in cutaneous T cell lymphoma. Dermatology 2004; 209: 296-300.
6. Al-Atrash G, Shetty S, Idell S et al. IL-2-mediated upregulation of uPA and uPAR in natural killer cells. Biochem Biophys Res Commun 2002; 292: 184-189.
7. Nykjaer A, M-ller B, Todd RF 3rd et al. Urokinase receptor. An activation antigen in human T lymphocytes. J Immunol 1994; 152: 505-516.
8. Shishido S, Satou H, Muramatsu M et al. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation. Clin Transplant 2013; 27: E143-E150.
9. Wandinger KP, Wessel K, Trillenberg P et al. Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients. Acta Neurol Scand 1998; 97: 359-365.